Morphea
☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
Leqeba la Morphea hangata le hlaha joalo ka patch ea atrophic pigmented.
References
Scleroderma ke lefu le sa tloaelehang le amang lisele tse hokahaneng, tse hlahang e le letlalo le thata 'me ka linako tse ling le ama likarolo tse ling tsa' mele. Ho na le mefuta e 'meli e meholo: systemic sclerosis , e kenyelletsang ho thatafala ha letlalo le litho tsa ka hare, le localized scleroderma , e tsejoang hape e le morphea, eo hangata e lulang e lekanyelitsoe letlalong le lisele tse ka tlas'a eona, ka mokhoa o bonolo le oa ho itšehla thajana. Le hoja scleroderma ea sebakeng seo e sa tloaeleha 'me sesosa sa eona se sa hlaka, lipatlisiso tsa morao-rao li fana ka maikutlo a hore e ka ama le litho tsa ka hare' me ea lebisa litabeng tse fapaneng tsa bophelo bo botle. Kalafo ea kapele e bohlokoa ho thibela mathata, ha ho nahanoa ka botebo bo ka bang teng ba localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.
Morphea , eo hape e tsejoang e le localized scleroderma, ke lefu le sa tloaelehang la autoimmune le amang lisele tse hokahaneng. E ka hlaha ka mekhoa e fapaneng, 'me ha e tloaelehe haholo, ka linyeoe tse ka bang 0. 4 - 2. 7 ho batho ba 100,000 selemo le selemo. Morphea hangata e bonoa ho bana ba pakeng tsa lilemo tse 2 le 14, 'me e atisa ho ama banana hangata ho feta bashanyana.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.
Morphea ke lefu le sa tloaelehang haholo. Ka lebaka la sebopeho sa foto, algorithm e kanna ea e fosahetse bakeng sa morphea.